Product Information
TACROLIMUS 0.03% OINTMENT is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.7954 per GM under NDC 68462088194. Its NADAC has been published 151 times since Oct 4, 2023.
FDA first approved this application on Apr 16, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.3 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462088194
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA210393FDA Approved
4/16/2018
TE Code
AB
On Market Since
8/16/2023
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.03% OINTMENT has been published 151 times since Oct 4, 2023, and over the history we have for it it has declined 20.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7954 per GM |
|---|---|
| All-time high | $1.0320 (Apr 10, 2024) |
| All-time low | $0.5757 (Apr 22, 2026) |
| 52-week high | $0.7954 |
| 52-week low | $0.5757 |
| Median price | $0.8134 |
| Average price | $0.7952 |
| Largest weekly change | +49.4% (Dec 20, 2023) |
| Weeks tracked | 151 |
| Tracking since | Oct 4, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.03% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.03% OINTMENT, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.7954 per GM (NDC 68462088194), effective Aug 19, 2026.
How has the price of TACROLIMUS 0.03% OINTMENT changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.03% OINTMENT has declined 20.8%. It has been tracked across 151 weekly CMS publications since Oct 4, 2023.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.03% OINTMENT?
Since Oct 4, 2023, the NADAC for TACROLIMUS 0.03% OINTMENT has ranged from a low of $0.5757 (Apr 22, 2026) to a high of $1.0320 (Apr 10, 2024), with a median of $0.8134 per GM.
Are there cheaper alternatives to TACROLIMUS 0.03% OINTMENT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 0.03% OINTMENT, is $0.5924 per GM — about 26% below TACROLIMUS 0.03% OINTMENT.
Who manufactures TACROLIMUS 0.03% OINTMENT?
TACROLIMUS 0.03% OINTMENT (NDC 68462088194) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.